IL2 and neoplasm: We treated mice with each factor-subtracted regimen (tumor presence, CTXpre, ex-T transfer, IL-2, and CD4post were removed from the full regimen) and analyzed the change in the ratio and number of IL-18Rαhi cells on day 25 (the same experiment scheme as shown in Fig. 4a).